These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25996838)

  • 1. Persistence of immunity in healthy adults aged ≥ 50 years primed with a hepatitis B vaccine 3 years previously.
    Sharma R; Ahlm C; Ostergaard L; Dowell A; Tran C; Thomas S; Eymin C
    Hum Vaccin Immunother; 2015; 11(7):1709-16. PubMed ID: 25996838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
    Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
    Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial.
    Raven SFH; Hoebe CJPA; Vossen ACTM; Visser LG; Hautvast JLA; Roukens AHE; van Steenbergen JE
    Lancet Infect Dis; 2020 Jan; 20(1):92-101. PubMed ID: 31629649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
    Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
    Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Persistence of immune memory to hepatitis B vaccine among infants with normal or high antibody response to primary vaccination: a five-year following-up study].
    Zhang L; Yan B; Liu J; Lyu J; Feng Y; Xu A; Song L; Liang X; Li L; Cui F; Zhang G; Wang F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1372-6. PubMed ID: 26850392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.
    Zanetti A; Desole MG; Romanò L; d'Alessandro A; Conversano M; Ferrera G; Panico MG; Tomasi A; Zoppi G; Zuliani M; Thomas S; Soubeyrand B; Eymin C; Lockhart S
    Vaccine; 2017 Jul; 35(32):4034-4040. PubMed ID: 28624307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
    Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
    Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
    BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults.
    Van Damme P; Dionne M; Leroux-Roels G; Van Der Meeren O; Di Paolo E; Salaun B; Surya Kiran P; Folschweiller N
    J Viral Hepat; 2019 Sep; 26(9):1066-1075. PubMed ID: 31087382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
    Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
    Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine.
    Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Deceuninck G; Massé R; Duval B
    Hum Vaccin; 2010 Feb; 6(2):212-8. PubMed ID: 19946212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Persistence of immune memory and its related factors at 12 years after hepatitis B vaccination among adults].
    Zhang L; Yan BY; Lyu JJ; Liu JY; Kong Q; Wu WL; Feng Y; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 May; 53(5):497-502. PubMed ID: 31091608
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune memory to hepatitis B persists in children aged 7-8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix™ hexa) vaccine.
    Van Der Meeren O; Bleckmann G; Crasta PD
    Hum Vaccin Immunother; 2014; 10(6):1682-7. PubMed ID: 24637296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
    Gilbert CL; Stek JE; Villa G; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
    Vaccine; 2014 Nov; 32(48):6521-6. PubMed ID: 25252192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
    Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to hepatitis B vaccine with high antigen content in non-responders after standard primary vaccination in Chinese adults.
    Pan HX; Zeng Y; Song XF; Zhang YJ; Xu K; Liang ZL; Zhu FC
    Vaccine; 2014 Jun; 32(29):3706-12. PubMed ID: 24681228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults.
    Wang H; Cai B; Rao D; Liu M; Li Y; Liang X; Cui F; Zhang G; Wang F; Pang X; Nie L; Qiu Q; Wu J; Li L; Huang F; Zhang W
    Hum Vaccin Immunother; 2016 Nov; 12(11):2921-2926. PubMed ID: 27648684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.